49.54 -0.12 (-0.24%)
After hours: 4:39PM EDT
|Bid||49.64 x 1400|
|Ask||49.65 x 800|
|Day's Range||49.19 - 49.89|
|52 Week Range||26.10 - 51.41|
|Beta (3Y Monthly)||1.46|
|PE Ratio (TTM)||42.48|
|Earnings Date||Jul 31, 2019 - Aug 5, 2019|
|Forward Dividend & Yield||0.16 (0.32%)|
|1y Target Est||49.50|
The launch of this system is in sync with NuVasive's (NUVA) endeavor to deliver end-to-end solutions that offer predictable clinical and economic outcomes in spine surgery.
Boston Scientific (BSX) is currently pinning hopes on a stronger performance in China, backed by the recent approval of SYNERGY in the country.
ResMed's (RMD) new product menu and an array of strategies are likely to benefit from the sleep-disordered breathing market. This should further drive its short-term performance.
Integra LifeSciences (IART) expects its partnership with Tissue Analytics to be perfectly strategic as the latter's software solutions automatically derive high quality data from clinical pictures.
The identification of a group of peptides and proteins is a remarkable step toward Phibro's (PAHC) development of a solution for ASF.
The sale of oncology bead products by Boston Scientific (BSX) is expected to be among the last steps undertaken by the company to obtain Federal Trade Commission's approval for BTG buyout.
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Acquisition strengthens Bruker's portfolio of high-performance PET molecular imaging solutions ZURICH , Switzerland , July 8, 2019 /PRNewswire/ -- Bruker today announced that it has acquired PMOD Technologies ...
Teleflex (TFX) issued a statement saying consumers who own the tampered product should immediately discontinue use and return all affected products.
Bruker (BRKR) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Methode Electronics' (MEI) fourth-quarter fiscal 2019 results suffer from weak automotive sales stemming from lower demand for passenger cars.